Palliative care: Aprepitant and control of emesis induced by 5-day chemotherapy.
Richard J
RJ
Gralla
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077608:Aprepitant; D002945:Cisplatin / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D009373:Neoplasms, Germ Cell and Embryonal / Q000150:complications / Q000188:drug therapy*; D010166:Palliative Care; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D009025:Morpholines; D000077608:Aprepitant; D002945:Cisplatin